End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
12.75 CNY | -2.52% | -2.97% | -14.94% |
Apr. 24 | HitGen Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Feb. 23 | HitGen Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Business Summary
Number of employees: 452
Sales per Business
CNY in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Deoxyribonucleic Acid Encoded Compound Library Screening Service
26.3
%
| - | - | 98 | 26.3 % | - |
Fragment-based Drug Design/Structure-based Drug Design Research & Development Services
24.5
%
| - | - | 91 | 24.5 % | - |
Deoxyribonucleic Acid Encoded Compound Library Customization Service
22.8
%
| - | - | 85 | 22.8 % | - |
Chemical Synthesis Services
14.0
%
| - | - | 52 | 14.0 % | - |
New Drug Custom Development
5.2
%
| - | - | 19 | 5.2 % | - |
Others
3.8
%
| - | - | 14 | 3.8 % | - |
Compound Structure Intellectual Property Transfer Fee
2.8
%
| - | - | 10 | 2.8 % | - |
New Drug Research Equity Transfer
0.5
%
| 17 | 5.2 % | 2 | 0.5 % | -88.90% |
Sales per region
CNY in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
67.3
%
| 164 | 49.8 % | 250 | 67.3 % | +52.21% |
China
16.9
%
| 69 | 20.8 % | 63 | 16.9 % | -8.40% |
Denmark
5.1
%
| 20 | 6.2 % | 19 | 5.1 % | -8.13% |
United Kingdom
3.9
%
| 11 | 3.3 % | 15 | 3.9 % | +33.50% |
Japan
2.6
%
| 5 | 1.4 % | 10 | 2.6 % | +103.57% |
South Korea
1.4
%
| 7 | 2.2 % | 5 | 1.4 % | -31.03% |
France
1.2
%
| 41 | 12.4 % | 5 | 1.2 % | -88.72% |
Other Countries
1.0
%
| 4 | 1.1 % | 4 | 1.0 % | +1.29% |
Germany
0.4
%
| 6 | 1.9 % | 1 | 0.4 % | -76.03% |
Ireland
0.2
%
| 3 | 0.8 % | 1 | 0.2 % | -70.11% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Jin Li
CEO | Chief Executive Officer | 61 | 12-02-21 |
Eliza Liu
DFI | Director of Finance/CFO | 54 | 23-04-26 |
Barry A Morgan
CTO | Chief Tech/Sci/R&D Officer | 77 | 16-05-31 |
Sui Bo Li
BRD | Director/Board Member | 63 | 18-09-30 |
Lei Zhu
IRC | Investor Relations Contact | 36 | 19-06-30 |
Shi Wei Geng
SEC | Corporate Secretary | 37 | 15-09-30 |
Guan Sai Liu
PRN | Corporate Officer/Principal | 42 | 13-08-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Jin Li
CEO | Chief Executive Officer | 61 | 12-02-21 |
Hai Zong Yu
BRD | Director/Board Member | 60 | 19-03-23 |
Jian Guo Li
BRD | Director/Board Member | 63 | 19-03-23 |
Yong Cun Chen
BRD | Director/Board Member | 59 | 19-03-23 |
Kai Lu
BRD | Director/Board Member | 71 | 12-01-31 |
Ze Wu Liu
BRD | Director/Board Member | 71 | 19-03-23 |
Chen Hui Xu
CHM | Chairman | 58 | 12-01-31 |
Dan Liu
BRD | Director/Board Member | 41 | 22-05-26 |
Sui Bo Li
BRD | Director/Board Member | 63 | 18-09-30 |
Shao Lin Hu
BRD | Director/Board Member | 38 | 22-05-26 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 400,680,000 | 134,070,359 ( 33.46 %) | 1,238,700 ( 0.3091 %) | 33.46 % |
Holdings
Name | Equities | % | Valuation |
---|---|---|---|
HITGEN INC. 0.31% | 1,238,700 | 0.31% | 2,312,678 $ |
Company contact information
Sector
Sales per Business
Sales per region
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-14.94% | 704M | |
+9.58% | 115B | |
+12.41% | 107B | |
-12.38% | 22.31B | |
-3.61% | 21.6B | |
-3.35% | 18.23B | |
-38.57% | 17.62B | |
+7.51% | 14.26B | |
+35.67% | 12.37B | |
-24.50% | 8.28B |
- Stock Market
- Equities
- 688222 Stock
- Company HitGen Inc.